XML 51 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity (Details Textual 1) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
May 19, 2016
Jun. 30, 2016
Dec. 31, 2015
Jun. 30, 2015
Dec. 31, 2014
Subsidiary, Sale of Stock [Line Items]          
Warrants Weighted Average Exercise Price   $ 5.27 $ 35.51 $ 34.63 $ 36.13
Number of warrants   1,756 205 180 171
Fair value of the derivative liability   $ 156      
IPO [Member]          
Subsidiary, Sale of Stock [Line Items]          
Proceeds from sale of stock, net $ 1,204        
Administrative and other offering expenses $ 780        
Number of shares sold in private placement 690        
Warrants Weighted Average Exercise Price $ 2.175        
Warrants, expiration date May 18, 2021        
Public offering price $ 1.74        
Number of warrants 345        
Warrants offering price $ 0.01        
Note Conversion [Member]          
Subsidiary, Sale of Stock [Line Items]          
Proceeds from sale of stock, net $ 1,188        
Number of shares sold in private placement 683        
Warrants Weighted Average Exercise Price $ 2.175        
Warrants, expiration date May 18, 2021        
Number of warrants 854        
Debt Instrument, Increase, Accrued Interest $ 120        
Fair value of the derivative liability $ 586        
Conversion price $ 1.74        
Deferred Compensation Conversion [Member]          
Subsidiary, Sale of Stock [Line Items]          
Proceeds from sale of stock, net $ 498        
Number of shares sold in private placement 286        
Warrants Weighted Average Exercise Price $ 2.175        
Warrants, expiration date May 18, 2021        
Number of warrants 352        
Debt Instrument, Increase, Accrued Interest $ 59        
Fair value of the derivative liability $ 244        
Conversion price $ 1.74